Eculizumab is a long-acting humanized monoclonal antibody that targets against complement C5. It stops the cleavage of C5 into C5a and C5b and hence inhibits the deployment of the terminal complement system such as forming of MAC.
Eculizumab-aagh Injection - An Overview
Eculizumab-aagh injection is used to treat paroxysmal nocturnal hemoglobinuria. Read the article below.
Eculizumab - A Wonder Drug for a Rare Blood Disorder
Eculizumab is recommended to reduce hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Read the article to learn more.
